Natural product-based therapy for pulmonary arterial hypertension: Agaricus blazei Murill, a medicinal mushroom, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene., 18.57

Vitamin-based therapy for Stroke: Vitamin-E inhibits cerebral ischemia induced injury via down regulation of its target gene, 30/January/2015, 18.45
January 30, 2015
Natural product-based therapy for pulmonary arterial hypertension: Monascin inhibits the development of pulmonary arterial hypertension via up regulation of its target gene, 30/January/2014, 19.05
January 30, 2015
Show all

A study from the University of California, La Jolla, CA, USA shows that Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of Nature Medicine by Prof. Thistlethwaite PA, Li X and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for pulmonary arterial hypertension: Agaricus blazei Murill, a medicinal mushroom, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene. Together, pharmacological formulations encompassing “Agaricus blazei Murill or small molecule compounds isolated from garicus blazei Murill may be used to treat pulmonary arterial hypertension.

Amount: $ 500

Undisclosed information: How IL-1β  decreases pulmonary arterial hypertension

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Natural product-based therapy for pulmonary arterial hypertension: Agaricus blazei Murill, a medicinal mushroom, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene.,  18.57,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.